SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a bold, unsolicited bid to acquire eBay, a move that has sparked intense debate regarding strategic viability, financing, and potential shareholder dilution. The community remains deeply polarized, with supporters viewing the aggressive move as a calculated long-term play, while skeptics and short sellers express concerns over the CEO's confrontational media presence and the logistical feasibility of the merger.

SKK Holdings Ltd. operates as a holding company, which engages in the provision of civil engineering services in subsurface utility works, including power and telecommunication cable laying, water pipeline and sewer rehabilitation works. The company was founded by Chun Seong Ng and Koon Kiat Sze on October 16, 2013 and is headquartered in Singapore.

SKK Holdings Ltd. - Ordinary Shares - Class A

SKK Holdings Ltd

SKK Holdings is trending due to a significant definitive asset purchase agreement to acquire Rantizo drone assets for over 250 million dollars, causing substantial volatility and trading halts. Community discussion is focused on the potential for a massive short squeeze and parabolic price action, fueled by the company's low float and the belief that the stock remains undervalued relative to the scale of the acquisition.

Skycorp Solar Group Ltd. is a holding company which designs, develops, manufactures and sells solar PV products and solar power system solutions services, through its indirectly wholly owned subsidiary. Its products include One-stop Solar system, Inverter, LFP Battery, Balcony Storage, and PV Cable. It operates through the following segments: Solar PV Products, High Performance Computing Products, and Others. The Solar PV Products segment includes servers, photovoltaic cable, and photovoltaic connectors. The High Performance Computing Products segment refers to the HPC servers and accessories delivered to the customers. The company was founded on January 19, 2022 and is headquartered in Ningbo, China.

Skycorp Solar Group Ltd. - Ordinary Shares - Class A

Skycorp Solar Group Ltd.

Skycorp Solar Group is trending following the announcement of a deal to acquire the remaining stake in Nanjing Cesun Power alongside a private placement, driving significant retail interest in its low-float structure. Community members are actively debating the potential for a parabolic squeeze, with many comparing its setup to recent low-float runners while skeptics highlight risks associated with previous share offerings and dilution.

Elong Power Holding Ltd. engages in the research and development, manufacturing, sales and service of high-power lithium-ion batteries for electric vehicles and construction machinery, as well as large-capacity, long-cycle lithium-ion batteries for energy storage systems. The company was founded on August 18, 2023 and is headquartered in Ganzhou, China.

Elong Power Holding Ltd. - Ordinary Shares - Class A

Elong Power Holding Limited

Elong Power Holding Limited is trending due to significant high-volatility price action and heavy turnover, as the community closely monitors critical support levels and discusses the stock's potential for short-squeeze setups. Traders are actively debating the impact of recent capital raises and the company's low-float structure, with sentiment heavily divided between those hunting for rapid parabolic gains and others warning of historical dilution risks.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) shares surged following a compromise in the CLARITY Act that preserves stablecoin reward programs under specific conditions. The community is actively debating the stock's long-term potential as a digital infrastructure leader, with many investors focusing on price consolidation patterns and upcoming earnings as the next major catalysts.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending following reports that GameStop has made an unsolicited offer to acquire the e-commerce platform in a multibillion-dollar cash-and-stock deal. While the community is debating the feasibility and potential dilution of such an acquisition, the news has sparked intense speculation regarding GameStop's broader strategic pivot toward high-end collectibles and marketplaces.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

Cns Pharmaceuticals is generating significant buzz due to an oversubscribed private placement financing and optimism surrounding its clinical-stage pipeline. The community is actively discussing its low float and the potential for a volatility-driven squeeze, with traders closely monitoring key support and resistance levels to gauge whether the upward momentum will continue.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors react to a major restructuring plan that includes 30,000 job cuts and a reduction in low-margin Amazon volume to drive future profitability. While some in the community see the move as a necessary step toward long-term margin improvement and efficiency, others are concerned about the impact of the workforce reduction, ongoing union dynamics, and competitive pressures.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as it reclaims the $80,000 level amid bullish sentiment fueled by the CLARITY Act's progress and increasing institutional activity. The community is actively debating the sustainability of this price action, with many traders focused on the potential for a massive short squeeze while others remain cautious of macroeconomic geopolitical tensions.

Twin Vee PowerCats Co. engages in the design, manufacture, and sale of recreational and commercial power catamaran boats. The firm is focused on designing and developing its products under the ELECTRA Power Sports brand. It operates through the Twin Vee PowerCats and Wizz Banger, Inc. Segments. The Twin Vee PowerCats segment designs, manufactures, and sells recreational and commercial powerboats. The Wizz Banger, Inc. segment refers to a development-stage subsidiary with plans to develop an innovative online marketplace leveraging artificial intelligence (AI) to transform how customers search for and purchase recreational marine assets. The company was founded by Roger Dunshee in 1996 and is headquartered in Fort Pierce, FL.

Twin Vee PowerCats Co

Twin Vee PowerCats is seeing high volatility and intense community focus as traders speculate on a potential short squeeze fueled by its low-float profile and high borrow costs. Sentiment is polarized between participants anticipating a parabolic move similar to recent sector runners and skeptics warning of a pump-and-dump cycle.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Institutional Giants Are Piling into Four of These NASDAQ Plays

The market is currently seeing a flurry of activity as companies across the biotech and technology sectors secure substantial funding and execute strategic transformations. $CNSP, $KBLB, $PN, $RLYB, $ADVB, $CLNN, $CABA

<ul class="summary-bullets"><li>CNS Pharmaceuticals plans to use the proceeds, along with existing cash, to identify and acquire new drug candidates in neurology and oncology.</li><li>The company is looking to out-license its legacy programs, including Berubicin and TPI-287, to treat tumors.</li><li>The biotech firm will look to acquire or license preclinical and clinical-stage assets with clear development paths and strong commercial potential.</li></ul>Shares of CNS Pharmaceuticals Inc. (CNSP) rocketed over 330% in early trade on Monday, registering their biggest ever single-day gains since implementing a 1-for-12 reverse stock split last July, as investors cheered a $22.5 million private placement to boost its acquisition strategy.The financing includes participation from institutional healthcare investors such as ADAR1 Capital, Ikarian Capital, Stonepine Capital Management, and Nazare Partners.The private placement involves the sale of 650,000 common shares at $2.30 each, along with pre-funded warrants tied to over 9.1 million shares. CNSP shares closed at $2.31 on Friday.“With the proceeds from this financing, the company is now in a strong position to execute on our recently announced corporate strategy and capitalize on opportunities created by the dynamic biotech environment over the last several years,” said Rami Levin, President and CEO of CNS Pharmaceuticals.<h2 class="st-heading-2">Strategic Shift Toward Acquisitions, Licensing</h2>CNS Pharmaceuticals plans to use the proceeds, along with existing cash, to identify and acquire new drug candidates in neurology and oncology. The company is prioritizing assets with clear development paths, strong scientific backing, and near-term catalysts.At the same time, the firm is looking to out-license its legacy programs, including Berubicin and TPI-287, to treat tumors.In March, CNS Pharmaceuticals <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://cnspharma.com/cns-pharmaceuticals-launches-new-corporate-strategy-focused-on-building-a-high-value-neurology-and-oncology-pipeline/">announced</a> a new growth strategy focused on building a strong pipeline in neurology and oncology. The biotech firm will look to acquire or license preclinical and clinical-stage assets, prioritizing programs with clear development paths and strong commercial potential.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/CNSP">CNSP</a> on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘extremely high’ message volumes.One user saw $11 to $12 as a key resistance level.<stembedurl>https://stocktwits.com/cjstocksup/message/652162741</stembedurl>However, another user expects the stock to drop “hard.”<stembedurl>https://stocktwits.com/belikemike7/message/652165417</stembedurl>The stock is up 70% year-to-date.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-xndu-stock-down-today-xanadu-quantum-share-registration/cZQMsDAReJ4">XNDU Stock Crashed 68%, But It’s Not A New Offering – Retail Traders Call It An ‘Overreaction’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

Why Did CNSP Stock Surge 330% Today?

The company announced a private placement, involving the sale of 650,000 common shares at $2.30 each, along with pre-funded warrants tied to over 9.1 million shares.

Equity

Nano-Cap CNS Pharmaceuticals Stock Explodes As Capital Raise Fuels Pivot

CNS Pharmaceuticals announces $22.5 million financing as the company pivots its strategy, eyes asset acquisitions.read more...

CNS Pharmaceuticals Secures $22.5 M in Oversubscribed Private Placement

CNS Pharmaceuticals (NASDAQ:CNSP) significantly boosted its capital reserves, entering into securities purchase agreements for a private placement expected to generate $22.5 million in gross proceeds.

Shares of CNS Pharmaceuticals, Inc. (CNSP) declined 5% on Friday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://cnspharma.com/ir/press-releases/cns-pharmaceuticals-announces-primary-analysis-of-berubicin-in-second-line-treatment-of-glioblastoma-multiforme-44471506">reported </a>wider losses in the first quarter (Q1).The firm’s net loss for the three months ended March 31, 2025, was approximately $4.3 million, compared to approximately $3.5 million for the comparable period in 2024.The company said the increase in net loss is largely attributable to the costs of data clean-up, preparation, and analysis for the topline primary data release on the Berubicin trial in brain cancer.CNS Pharmaceuticals’ research and development expenses rose to $3.2 million in the quarter, while general and administrative expenses fell marginally to $1.09 million, owing to a decrease in stock-based compensation, marketing, advertising, and insurance expenses.The company ended the quarter with cash of approximately $13.1 million. CNS believes that the cash on hand as of March 31, 2025, in addition to the $5 million raised from a public offering earlier this month, is sufficient to fund planned operations into the second half of 2026.CNS is developing treatments for cancers in the brain and central nervous system. By year-end, the company intends to commence the phase 2 study of its lead program, TPI 287, for treating Glioblastoma Multiforme (GBM). Glioblastoma multiforme (GBM) is the most common form of cancer that originates in the brain.On Stocktwits, retail sentiment around CNSP remained ‘extremely bullish’ over the past 24 hours while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:627/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_16_at_9_01_42_AM_png_cf9bcf9c43.webp" alt="CNSP's Sentiment Meter and Message Volume as of 9 a.m. ET on May 16, 2025 | Source: Stocktwits" width="627" height="63"><figcaption>CNSP's Sentiment Meter and Message Volume as of 9 a.m. ET on May 16, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/CNSP">CNSP stock</a> is down by 80% this year and over 99% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-ceo-to-step-down/chiw5m5Rbno">Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved

The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.

This account has been verified as an official CNSP representative.

Verified Account

CNS Pharma

Continue higher

Sideways action

Retreat lower

What’s your read on the market for next week?

Stocktwits

Stocktwits Polls

Traders are closely tracking high-volatility micro-cap stocks with low float counts that are exhibiting massive price swings.

Investors are debating the implications of a $22.5 million private placement financing, weighing validation against potential dilution concerns.

Market participants are scanning for high-interest, thinly traded assets potentially primed for aggressive short-covering rallies.

Current Price	$8.81
Prev Close	$2.31
Open	$9.20
Dividend Yield	0.00%
50-Day Moving Average	$2.59
Beta	1.14
Avg. Volume	24,734.92
PE Ratio	-0.06

52-Week High	$34.80
52-Week Low	$1.90
Market Capitalization	$1.88M
EPS (Annual)	-$35.75
Price to Book	0.32
Revenue Per Employee	$0.00

CNSP
Cns Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Latest CNSP News

CNSPCns Pharmaceuticals Inc